Specify a stock or a cryptocurrency in the search bar to get a summary
Brainsway Ltd
BWAYBrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. Address: Bynet Building, Jerusalem, Israel, 9777518
Analytics
WallStreet Target Price
12.4 USDP/E ratio
395.5Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures BWAY
Dividend Analytics BWAY
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BWAY
Stock Valuation BWAY
Financials BWAY
Results | 2019 | Dynamics |